Alternative splicing as a biomarker and potential target for drug discovery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative splicing as a biomarker and potential target for drug discovery
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 36, Issue 10, Pages 1212-1218
Publisher
Springer Nature
Online
2015-06-15
DOI
10.1038/aps.2015.43
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing
- (2014) Maayan Salton et al. NUCLEIC ACIDS RESEARCH
- The alternative splicing side of cancer
- (2014) Giuseppe Biamonti et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer
- (2013) Fan Zhang et al. BMC Systems Biology
- Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
- (2013) Bishakha Roy et al. CURRENT GENOMICS
- New developments in the use of gene therapy to treat Duchenne muscular dystrophy
- (2013) Susan Jarmin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genomics of alternative splicing: evolution, development and pathophysiology
- (2013) Eric R. Gamazon et al. HUMAN GENETICS
- Coherence between Cellular Responses andin VitroSplicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs
- (2013) Kerstin A. Effenberger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MBNL proteins repress ES-cell-specific alternative splicing and reprogramming
- (2013) Hong Han et al. NATURE
- MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells
- (2013) Andrea Turner et al. PLoS One
- MBNL1 42 and MBNL1 43 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
- (2013) A Botta et al. Cell Death & Disease
- RBM5 Is a Male Germ Cell Splicing Factor and Is Required for Spermatid Differentiation and Male Fertility
- (2013) Moira K. O'Bryan et al. PLoS Genetics
- Alternative RNA splicing and cancer
- (2013) Sali Liu et al. Wiley Interdisciplinary Reviews-RNA
- Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing
- (2012) M Ri et al. Blood Cancer Journal
- Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells
- (2011) Liang-Cheng Li et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
- (2011) Clare V LeFave et al. EMBO JOURNAL
- Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
- (2009) T. Rodriguez-Martin et al. HUMAN MOLECULAR GENETICS
- Tissue-specific alternative splicing of TCF7L2
- (2009) Ludmila Prokunina-Olsson et al. HUMAN MOLECULAR GENETICS
- Regulation of Apoptosis and Caspase-8 Expression in Neuroblastoma Cells by Isoforms of the IG20 Gene
- (2008) L. C. Li et al. CANCER RESEARCH
- Identification of Alternative Splicing Markers for Breast Cancer
- (2008) J. P. Venables et al. CANCER RESEARCH
- Role of IG20 Splice Variants in TRAIL Resistance
- (2008) B. S. Prabhakar et al. CLINICAL CANCER RESEARCH
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started